文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于纳米载体的肾脏疾病局部有效治疗:当前采用的靶向策略。

Nanocarrier-based localized and effective treatment of renal disorders: currently employed targeting strategies.

机构信息

Department of Pharmaceutical Sciences, Faculty of Pharmacy, Superior University, Lahore, Punjab, 54000, Pakistan.

Department of Pharmacology, Jinnah Sindh Medical University, Karachi, 75510, Pakistan.

出版信息

Nanomedicine (Lond). 2024 Feb;19(4):345-361. doi: 10.2217/nnm-2023-0251. Epub 2024 Jan 31.


DOI:10.2217/nnm-2023-0251
PMID:38293889
Abstract

Renal disorders pose a global health threat, with targeted drug-delivery systems emerging as a promising strategy to enhance therapy safety and efficacy. Recent efforts have harnessed targeted nanomaterials for kidney disease treatment. While some systems remain in the early stages, they show immense potential in delivering cargo to specific sites. Through animal model experimentations, it has been demonstrated to reduce systemic side effects and enhance treatment effectiveness. This review presents current strategies for kidney disorder treatment, emphasizing site-specific targeting critical to renal disease pathophysiology. Recent advancements in nano-drug delivery systems for kidney targeting are explored. Finally, toxicological aspects and prospects of the most promising kidney-targeting delivery systems are discussed in this review article.

摘要

肾脏疾病对全球健康构成威胁,靶向药物输送系统作为一种提高治疗安全性和疗效的有前途的策略而出现。最近的研究利用靶向纳米材料来治疗肾脏疾病。虽然一些系统仍处于早期阶段,但它们在将药物输送到特定部位方面显示出巨大的潜力。通过动物模型实验,已经证明可以减少全身副作用并提高治疗效果。本文综述了目前用于治疗肾脏疾病的策略,强调了针对肾脏疾病病理生理学的特定部位靶向的重要性。探讨了用于肾脏靶向的纳米药物输送系统的最新进展。最后,本文讨论了最有前途的肾脏靶向输送系统的毒理学方面和前景。

相似文献

[1]
Nanocarrier-based localized and effective treatment of renal disorders: currently employed targeting strategies.

Nanomedicine (Lond). 2024-2

[2]
A quantitative review of nanotechnology-based therapeutics for kidney diseases.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024

[3]
Advancement in transporter-oriented nanoplatforms for cancer therapy.

J Drug Target. 2023-6

[4]
A pH-Responsive System Based on Fluorescence Enhanced Gold Nanoparticles for Renal Targeting Drug Delivery and Fibrosis Therapy.

Int J Nanomedicine. 2020-8-6

[5]
Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules.

Med Res Rev. 2018-8-22

[6]
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

Eur J Pharm Biopharm. 2015-6

[7]
Advances in drug delivery-based therapeutic strategies for renal fibrosis treatment.

J Mater Chem B. 2024-7-10

[8]
Targeted nanotherapy for kidney diseases: a comprehensive review.

Nephrol Dial Transplant. 2023-5-31

[9]
Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.

Curr Pharm Des. 2021

[10]
Renal Nano-drug delivery for acute kidney Injury: Current status and future perspectives.

J Control Release. 2022-3

引用本文的文献

[1]
Polymeric Nanomedicines in Diabetic Wound Healing: Applications and Future Perspectives.

Int J Nanomedicine. 2025-5-22

[2]
Enzyme-activatable kidney-targeted dendrimer-drug conjugate for efficient childhood nephrotic syndrome therapy.

Theranostics. 2024-10-21

[3]
" philosophy" for the design of anticancer drug delivery nanoparticles.

Biomater Transl. 2024-6-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索